Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients

Status:
Terminated

Trial end date:
2006-03-01

Target enrollment:

Participant gender:

To investigate the long-term safety and tolerability of repeated doses of degarelix to prostate cancer patients

Phase 2

Ferring Pharmaceuticals